Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine-Reference-Cited by-同舟云学术

Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine

Published:2014-09 Issue:1 Volume:161 Page:20-30
ISSN:0165-2478
Container-title:Immunology Letters
language:en
Short-container-title:Immunology Letters

Author:

Ohtake Junya,Ohkuri Takayuki,Togashi Yuji,Kitamura Hidemitsu,Okuno Kiyotaka,Nishimura Takashi

Funder

Scientific Research

Ministry of Education, Culture, Sports, Science, and Technology

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma;Ambrosini;Nat Med,1997

2. An HLA-A24-restricted cytotoxic T lymhocyte epitope of a tumor-associated protein, survivin;Hirohashi;Clin Cancer Res,2002

3. Multiple roles for CD4+ T cells in anti-tumor immune responses;Kennedy;Immunol Rev,2008

4. FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens;Klarnet;J Exp Med,1989

5. Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo;Nishimura;J Exp Med,1999

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complete Cure of Inoperable Stage IV Locally Advanced Hypopharyngeal Squamous Cell Carcinoma by an Innovative Combination Cancer Immunotherapy Consisting of Radiation, Immune Checkpoint Inhibitors, and Dendritic Cell Vaccine;Cureus;2024-09-14

2. Old concepts, new tricks: How peptide vaccines are reshaping cancer immunotherapy?;International Journal of Biological Macromolecules;2024-09

3. New Vaccine Therapy for Triple-Negative Breast Cancer;Current Breast Cancer Reports;2024-05-08

4. SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity;Heliyon;2023-09

5. Peptide-Based Vaccine against Breast Cancer: Recent Advances and Prospects;Pharmaceuticals;2023-06-25